Related references
Note: Only part of the references are listed.Differential Plasma Metabolites between High- and Low-Grade Meningioma Cases
Gabriel A. Kurokawa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2021)
Insulin signaling mediates neurodegeneration in glioma
Patricia Jarabo et al.
LIFE SCIENCE ALLIANCE (2021)
Glycolysis and Fatty Acid Oxidation Inhibition Improves Survival in Glioblastoma
Kelly J. McKelvey et al.
FRONTIERS IN ONCOLOGY (2021)
Proline/arginine dipeptide repeat polymers derail protein folding in amyotrophic lateral sclerosis
Maria Babu et al.
NATURE COMMUNICATIONS (2021)
Metabolomics: small molecules that matter more
Balasubramanian Chellammal Muthubharathi et al.
MOLECULAR OMICS (2021)
MAPK pathway: Potential role in glioblastoma multiforme
Kowthavarapu V. Krishna et al.
INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT (2021)
Enhanced fatty acid oxidation provides glioblastoma cells metabolic plasticity to accommodate to its dynamic nutrient microenvironment
Shiva Kant et al.
CELL DEATH & DISEASE (2020)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2020)
Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma
Rui-Chao Chai et al.
CARCINOGENESIS (2019)
A review of validated biomarkers obtained through metabolomics
Angeles Lopez-Lopez et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
PI3K activation in neural stem cells drives tumorigenesis which can be ameliorated by targeting the cAMP response element binding protein
Paul M. Daniel et al.
NEURO-ONCOLOGY (2018)
Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome
Shiran Ferber et al.
ELIFE (2017)
Insights into molecular therapy of glioma: current challenges and next generation blueprint
Y. Rajesh et al.
ACTA PHARMACOLOGICA SINICA (2017)
Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions
Sameer Agnihotri et al.
NEURO-ONCOLOGY (2016)
C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles
Kyung-Ha Lee et al.
CELL (2016)
Hallmarks of glioblastoma: a systematic review
Dorte Schou Noroxe et al.
ESMO OPEN (2016)
Metabolic reprogramming of pyruvate dehydrogenase is essential for the proliferation of glioma cells expressing mutant IDH1
Pavithra Viswanath et al.
MOLECULAR & CELLULAR ONCOLOGY (2016)
Amyloidogenicity of p53: A Hidden Link Between Protein Misfolding and Cancer
Hao Gong et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2015)
Global Profiling of Metabolic Adaptation to Hypoxic Stress in Human Glioblastoma Cells
Paulina Kucharzewska et al.
PLOS ONE (2015)
Tet oxidizes thymine to 5-hydroxymethyluracil in mouse embryonic stem cell DNA
Toni Pfaffeneder et al.
NATURE CHEMICAL BIOLOGY (2014)
Phosphatidylserine in the brain: Metabolism and function
Hee-Yong Kim et al.
PROGRESS IN LIPID RESEARCH (2014)
TETonic shift: biological roles of TET proteins in DNA demethylation and transcription
William A. Pastor et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Ceramide-orchestrated signalling in cancer cells
Samy A. F. Morad et al.
NATURE REVIEWS CANCER (2013)
Alterations of metabolic genes and metabolites in cancer
Eric K. Oermann et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Glycogen synthesis is induced in hypoxia by the hypoxia-inducible factor and promotes cancer cell survival
Joffrey Pelletier et al.
FRONTIERS IN ONCOLOGY (2012)
Current Trends in Targeted Therapies for Glioblastoma Multiforme
Fumiharu Ohka et al.
NEUROLOGY RESEARCH INTERNATIONAL (2012)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Method for lipidomic analysis: p53 expression modulation of sulfatide, ganglioside, and phospholipid composition of U87 MG glioblastoma cells
Huan He et al.
ANALYTICAL CHEMISTRY (2007)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
The ERK cascade - A prototype of MAPK signaling
H Rubinfeld et al.
MOLECULAR BIOTECHNOLOGY (2005)
Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue
G Petersen et al.
JOURNAL OF NEUROCHEMISTRY (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Levels of 5-hydroxymethyl-2 '-deoxyuridine in DNA from women participating in an intervention trial of low-fat and low-energy diets
Z Djuric et al.
BIOMARKERS (2004)
The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis
M Maccarrone et al.
CELL DEATH AND DIFFERENTIATION (2003)
Oxidative DNA damage: mechanisms, mutation, and disease
MS Cooke et al.
FASEB JOURNAL (2003)
Glucosylceramide synthase and apoptosis
RJ Bleicher et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Selectins: lectins that initiate cell adhesion under flow
RP McEver
CURRENT OPINION IN CELL BIOLOGY (2002)
Anandamide and other N-acylethanolamines in human tumors
PC Schmid et al.
LIPIDS (2002)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3) -: Role of phosphatidylserine in antiapoptotic effect
HY Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)